Robert Essner is the retired chairman and CEO of Wyeth, which was one of the world's leading research-based pharmaceutical companies. He led the transformation of Wyeth into a science-based industry leader with strong positions in drugs, biotechnology, vaccines, nonprescription products and animal health. During his more than 30 years in the industry, Mr. Essner served as chairman of both U.S. and global pharmaceutical organizations. He is a director of MassMutual, NBTY, PPDI, Amicus Therapeutics, and the Children's Health Fund, and is a Senior Advisor to The Carlyle Group. Mr. Essner is a graduate of Miami University and the University of Chicago. Areas of interest: general management, marketing, healthcare, pharmaceuticals, biotechnology.